Md. Code, Health Occupations § 14-5E-01

(a) In this subtitle the following words have the meanings indicated.

(b) “Board” means the State Board of Physicians.

(c) “Committee” means the Perfusion Advisory Committee established under § 14–5E–05 of this subtitle.

(d) “License” means a license issued by the Board to practice perfusion.

(e) “Licensed perfusionist” means a perfusionist who is licensed by the Board under this subtitle to practice perfusion.

(f) (1) “Practice perfusion” means to perform the functions necessary for the support, treatment, measurement, or supplementation of the cardiovascular, circulatory, or respiratory systems, or other organs to ensure the safe management of physiologic functions by monitoring and analyzing the parameters of the systems under an order and the supervision of a licensed physician.

(2) “Practice perfusion” includes:

(i) Cardiopulmonary bypass for adult, pediatric, and neonatal patients;

(ii) Extracorporeal circulatory support for renal, neurological, hepatic, and vascular surgery;

(iii) Extracorporeal resuscitation;

(iv) Extracorporeal circulation for long–term support of failing respiratory or cardiac function;

(v) Extracorporeal membrane oxygenation;

(vi) Extracorporeal carbon dioxide removal;

(vii) Myocardial protection;

(viii) Perfusion–assisted direct coronary artery bypass;

(ix) Hemofiltration and hemodialysis;

(x) Anticoagulation and hemostasis monitoring, analysis, and intervention;

(xi) Thermal regulation;

(xii) Blood gas and blood chemistry monitoring, analysis, and intervention;

(xiii) Physiological monitoring, analysis, and intervention;

(xiv) Administration of blood components and pharmaceuticals;

(xv) Administration of anesthetic agents through a heart lung machine at the direction of an anesthesiologist;

(xvi) Ventricular assist device and mechanical circulatory support management;

(xvii) Intra–aortic balloon counterpulsation;

(xviii) Temporary pacemaker management;

(xix) Periodic flow augmentation therapy;

(xx) Autotransfusion;

(xxi) Platelet gel production, autologous hemocyte tissue matrix production;

(xxii) Nondifferentiated progenitor cell harvest bone marrow aspirate concentrate;

(xxiii) Acute normovolemic hemodilution;

(xxiv) Isolated limb or organ delivery of chemotherapeutics, progenitor cells, gene therapy vectors, and other items;

(xxv) Organ procurement and preservation;

(xxvi) Thermogenic lavage;

(xxvii) Electrophysiological analysis;

(xxviii) Therapeutic hyperthermia;

(xxix) Intravascular membrane oxygenation; and

(xxx) Renal perfusion.

(g) “Student” means an individual who, in accordance with § 14–5E–09(c) of this subtitle, is:

(1) Enrolled in an accredited educational program to qualify for a license under this subtitle; and

(2) Performing perfusion services within the accredited program under the supervision of a licensed perfusionist and without compensation.

(h) “Supervision” means the responsibility of a licensed physician to exercise on site or immediately available direction for a licensed perfusionist to ensure the safety and welfare of patients during the course of perfusion.